Fakultni Nemocnice Ostrava; Klinika hematoonkologie FNO a LF OU

Ostrava 708 52

0 studies enrolling now · 1 studies all time

What they study most

Multiple Sclerosis, Relapsing-Remitting

Studies at this site

• A Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis — Completed